Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,831.70
-3.5908-0.20%
Number of Gainers:2
Number of Losers:17
Number of Flat:- -
PE:- -
High:1,844.83
Open:1,843.77
Low:1,825.88
Close:1,835.29
Volume:94.13M
Turnover:5.53B
Market Cap:1.49T
Float Cap:1.46T

Loading ...

Pfizer’s New Asthma Candidate PF-08103402 Enters Phase 1: What Investors Should Know

TIPRANKS
·
Sep 03

AstraZeneca PLC Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 03

Top AI Healthcare Stocks For September 2026

Simply Wall St.
·
Sep 02

LIVE Markets-Wall Street Starts Slow, Dow Leads

Reuters
·
Sep 02

Johnson & Johnson Stock (JNJ) Opened Up by 3.15% on Sep 2: Key Drivers Unveiled

TradingKey
·
Sep 02

Johnson & Johnson, Boeing Share Gains Contribute to Dow's 250-Point Climb

Dow Jones
·
Sep 02

Unusually active option classes on open September 2nd

TIPRANKS
·
Sep 02

Lakeland Wins Airports of Thailand ARFF Protective Equipment Supply Contract

Reuters
·
Sep 02

Equillium to Join Cantor Global Healthcare Conference 2026 Fireside Chat

Reuters
·
Sep 02

Lakeland Fire + Safety Awarded Airfield Rescue and Fire Fighting Protective Equipment Contract with Airports of Thailand

THOMSON REUTERS
·
Sep 02

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.
·
Sep 02

BioNTech (BNTX) Halts Cancer Trial, Is The 15% Undervaluation Still Credible?

Simply Wall St.
·
Sep 02

Johnson & Johnson : UBS Raises Target Price to $320 from $280

THOMSON REUTERS
·
Sep 02

Pfizer (PFE) Following FDA Vaccine Approval Has Fair Value Back In Focus

Simply Wall St.
·
Sep 02

Johnson & Johnson EVP Thomas Cavanaugh Files Initial Beneficial Ownership Statement

Reuters
·
Sep 02

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 02

Moderna Plans Private Placement of $2 Billion Convertible Senior Notes Due 2032

Reuters
·
Sep 02

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 02

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

Dow Jones
·
Sep 02

iBio CEO Joins Wells Fargo Annual Healthcare Conference Fireside Chat

Reuters
·
Sep 02